117 related articles for article (PubMed ID: 16181634)
1. Statistical evaluation for detection of peptide specific interferon-gamma secreting T-cells induced by HIV vaccine determined by ELISPOT assay.
Periwal SB; Spagna K; Shahabi V; Quiroz J; Shroff KE
J Immunol Methods; 2005 Oct; 305(2):128-34. PubMed ID: 16181634
[TBL] [Abstract][Full Text] [Related]
2. Functional T cell subsets contribute differentially to HIV peptide-specific responses within infected individuals: correlation of these functional T cell subsets with markers of disease progression.
Peretz Y; Ndongala ML; Boulet S; Boulassel MR; Rouleau D; Côté P; Longpré D; Routy JP; Falutz J; Tremblay C; Tsoukas CM; Sékaly RP; Bernard NF
Clin Immunol; 2007 Jul; 124(1):57-68. PubMed ID: 17521962
[TBL] [Abstract][Full Text] [Related]
3. Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma.
Abaitua F; Rodríguez JR; Garzón A; Rodríguez D; Esteban M
Virus Res; 2006 Mar; 116(1-2):11-20. PubMed ID: 16214252
[TBL] [Abstract][Full Text] [Related]
4. Efficient augmentation of a long-lasting immune responses in HIV-1 gag DNA vaccination by IL-15 plasmid boosting.
Li W; Li S; Hu Y; Tang B; Cui L; He W
Vaccine; 2008 Jun; 26(26):3282-90. PubMed ID: 18472194
[TBL] [Abstract][Full Text] [Related]
5. [Immunodominance in CD8+ T cell responses to HIV-1 synthesized epitopes].
Tang YB; Tang XP; Jin X
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Sep; 21(3):217-9. PubMed ID: 17971925
[TBL] [Abstract][Full Text] [Related]
6. [Intranasal priming with HIV DNA vaccine and systemic boosting with recombinant vaccinia induce vigorous immune responses: experiment with mice].
Huang XG; Xu JQ; Ren L; Qiu C; Zhang N; Liu LX; Wan YM; Peng H; Shao YM
Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(44):3109-13. PubMed ID: 17313761
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the interlaboratory concordance in quantification of human immunodeficiency virus-specific T cells with a gamma interferon enzyme-linked immunospot assay.
Samri A; Durier C; Urrutia A; Sanchez I; Gahery-Segard H; Imbart S; Sinet M; Tartour E; Aboulker JP; Autran B; Venet A;
Clin Vaccine Immunol; 2006 Jun; 13(6):684-97. PubMed ID: 16760328
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of cytomegalovirus-specific T-cell reconstitution in patients after various allogeneic haematopoietic stem cell transplantation using interferon-gamma-enzyme-linked immunospot and human leucocyte antigen tetramer assays with an immunodominant T-cell epitope.
Ohnishi M; Sakurai T; Heike Y; Yamazaki R; Kanda Y; Takaue Y; Mizoguchi H; Kawakami Y
Br J Haematol; 2005 Nov; 131(4):472-9. PubMed ID: 16281937
[TBL] [Abstract][Full Text] [Related]
9. Helminth infection suppresses T-cell immune response to HIV-DNA-based vaccine in mice.
Da'Dara AA; Lautsch N; Dudek T; Novitsky V; Lee TH; Essex M; Harn DA
Vaccine; 2006 Jun; 24(24):5211-9. PubMed ID: 16675073
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility to opportunistic infections in HIV-infected patients with increased CD4 T-cell counts on antiretroviral therapy may be predicted by markers of dysfunctional effector memory CD4 T cells and B cells.
French M; Keane N; McKinnon E; Phung S; Price P
HIV Med; 2007 Apr; 8(3):148-55. PubMed ID: 17461858
[TBL] [Abstract][Full Text] [Related]
11. Statistical considerations for the design and analysis of the ELISpot assay in HIV-1 vaccine trials.
Hudgens MG; Self SG; Chiu YL; Russell ND; Horton H; McElrath MJ
J Immunol Methods; 2004 May; 288(1-2):19-34. PubMed ID: 15183082
[TBL] [Abstract][Full Text] [Related]
12. Interferon-gamma ELISPOT assay for the quantitative measurement of antigen-specific murine CD8+ T-cells.
Cole GA
Methods Mol Biol; 2005; 302():191-204. PubMed ID: 15937353
[TBL] [Abstract][Full Text] [Related]
13. Safety and immunogenicity of cytotoxic T-lymphocyte poly-epitope, DNA plasmid (EP HIV-1090) vaccine in healthy, human immunodeficiency virus type 1 (HIV-1)-uninfected adults.
Gorse GJ; Baden LR; Wecker M; Newman MJ; Ferrari G; Weinhold KJ; Livingston BD; Villafana TL; Li H; Noonan E; Russell ND;
Vaccine; 2008 Jan; 26(2):215-23. PubMed ID: 18055072
[TBL] [Abstract][Full Text] [Related]
14. The adjuvancy of OX40 ligand (CD252) on an HIV-1 canarypox vaccine.
Liu J; Ngai N; Stone GW; Yue FY; Ostrowski MA
Vaccine; 2009 Aug; 27(37):5077-84. PubMed ID: 19573639
[TBL] [Abstract][Full Text] [Related]
15. [Cellular immune responses of recombinant hepatitis B (rHB) vaccine and HBsAG derived from Hansenula polymorpha cells].
Hu ZY; He P; Zhang R; Fang X; Zhu FC; Qiu SH; Li HM; Wang H; Liang ZL; Zhuang H
Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Jul; 29(7):706-11. PubMed ID: 19031766
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of immunogenicity and efficacy of combined DNA and adjuvanted protein vaccination in a human immunodeficiency virus type 1/murine leukemia virus pseudotype challenge model.
Rollman E; Mathy N; Bråve A; Boberg A; Kjerrström A; van Wely C; Engström G; Johansson S; Aperia K; Eriksson LE; Benthin R; Ertl P; Heeney J; Hinkula J; Voss G; Wahren B
Vaccine; 2007 Mar; 25(11):2145-54. PubMed ID: 17254672
[TBL] [Abstract][Full Text] [Related]
17. Inter-operator variation in ELISPOT analysis of measles virus-specific IFN-gamma-secreting T cells.
Ryan JE; Ovsyannikova IG; Dhiman N; Pinsky NA; Vierkant RA; Jacobson RM; Poland GA
Scand J Clin Lab Invest; 2005; 65(8):681-9. PubMed ID: 16319042
[TBL] [Abstract][Full Text] [Related]
18. Detection of measles virus-specific interferon-gamma-secreting T-cells by ELISPOT.
Ryan JE; Ovsyannikova IG; Poland GA
Methods Mol Biol; 2005; 302():207-18. PubMed ID: 15937354
[TBL] [Abstract][Full Text] [Related]
19. HIV-1 DNA vaccine efficacy is enhanced by coadministration with plasmid encoding IFN-alpha.
Jiang W; Ren L; Jin N
J Virol Methods; 2007 Dec; 146(1-2):266-73. PubMed ID: 17868910
[TBL] [Abstract][Full Text] [Related]
20. [Evolution of IGRA researches].
Ariga H; Harada N
Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]